Teva Kicks Off ‘The Other TD’ to Raise Awareness of Tardive Dyskinesia (TD), with Support from Pro Football Hall of Famer Terrell Davis

Group 1: Campaign Overview - Teva Pharmaceuticals launched 'The Other TD' campaign to raise awareness about tardive dyskinesia (TD), a lesser-known condition affecting individuals on certain mental health medications [1][8] - The campaign aims to educate undiagnosed Americans about TD symptoms and encourage discussions with healthcare providers [1][3] Group 2: Tardive Dyskinesia Statistics - Approximately 15.4 million Americans live with serious mental illnesses, with 25% of those on specific treatments potentially developing TD [2][8] - TD affects an estimated 785,000 Americans, yet only about 15% receive a formal diagnosis and merely 5% receive treatment [4][8] Group 3: Impact of Tardive Dyskinesia - TD can severely impact daily functioning, with three out of four individuals reporting significant effects on their emotional, social, and functional lives [4][8] - The disorder is particularly underdiagnosed among younger individuals, men, and racial and ethnic minorities, including Black Americans [4][8] Group 4: Educational Resources - 'The Other TD' campaign provides educational resources about recognizing TD symptoms and available treatment options, emphasizing that treatment can occur without disrupting mental health progress [3][5]